Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference60 articles.
1. Exploiting tumor neoantigens to target cancer evolution: current challenges and promising therapeutic approaches;Gupta;Cancer Discovery,2021
2. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer;Tilekar;Biochim. Biophys. Acta, Rev. Cancer,1874
3. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine;Bashraheel;Biomed. Pharmacother.,2020
4. Targeting topoisomerase I in the era of precision medicine;Thomas;Clin. Cancer Res.,2019
5. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer;Spinello;Eur. J. Med. Chem.,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements;Journal of Molecular Structure;2024-01
2. Novel dihydrobenzofuran derivatives: design, synthesis, cytotoxic activity, apoptosis, molecular modelling and DNA binding studies;J BIOMOL STRUCT DYN;2023
3. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors;Future Medicinal Chemistry;2023-01
4. Discovery of pyrazole‐carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti‐tumor candidates;Drug Development Research;2022-11-25
5. Development of New Thiophene-Containing Triaryl Pyrazoline Derivatives as PI3Kγ Inhibitors;Molecules;2022-04-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3